sulpiride has been researched along with levodopa in 100 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 44 (44.00) | 18.7374 |
1990's | 33 (33.00) | 18.2507 |
2000's | 11 (11.00) | 29.6817 |
2010's | 11 (11.00) | 24.3611 |
2020's | 1 (1.00) | 2.80 |
Authors | Studies |
---|---|
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Campillo, NE; Guerra, A; Páez, JA | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Barber, S; Dew, TP; Farrell, TL; Poquet, L; Williamson, G | 1 |
Donatelli, L | 1 |
Zanoboni, A; Zanoboni-Muciaccia, W; Zanussi, C | 2 |
Honda, F; Mori, J; Satoh, H; Satoh, Y | 1 |
Dumas, M; Dumond, JJ; Garoux, R; Leger, JM; Lombertie, E | 1 |
Kobayashi, I; Mori, M; Nemoto, T; Shimoyama, S; Uehara, T | 1 |
Durocher, AM; Graux, P | 1 |
Delitala, G | 1 |
Copinschi, G; Denayer, P; Golstein, J; L'Hermite, M; Robyn, C; Vanhaelst, L; Virasoro, E | 1 |
Caufriez, A; Degueldre, M; Delvoye, P; L'Hermite, M; Robyn, C | 1 |
Loizzo, A; Longo, VG; Mora, S | 1 |
Kato, Y | 1 |
Baudry, M; Martres, MP; Schwartz, JC | 1 |
Chihara, K; Iwasaki, Y; Kato, Y; Maeda, K; Ohgo, S | 1 |
Gräf, HJ; Horowski, R | 1 |
Barreca, T; Masturzo, P; Polleri, A; Rolandi, E | 1 |
Barreca, T; Cicchetti, V; Gianrossi, R; Masturzo, P; Rolandi, E | 1 |
Gershanik, O; Luquin, MR; Obeso, JA; Scipioni, O; Vaamonde, J | 1 |
Bernardi, G; Calabresi, P; Mercuri, NB | 3 |
Bianchi, R; Bircher, B; Duss, I; Fisch, HU; Groner, M; Groner, R; Hofer, D; Koelbing, U; Walder, F | 1 |
Paalzow, GH | 1 |
Greiner, HE; Haase, AF; Seyfried, CA | 1 |
Goshima, Y; Misu, Y; Nakamura, S | 1 |
Aceves, J; Floran, B; Hernandez, S; Mariscal, S; Martinez-Fong, D; Sierra, A | 1 |
Goto, I; Harada, M; Kira, J; Shida, N; Yamaguchi, Y | 1 |
Davis, A; Jenner, P; Marsden, CD | 1 |
Close, SP; Elliott, PJ; Hayes, AG; Marriott, AS; Walsh, DM | 1 |
Gershanik, OS; Rubinstein, M; Stefano, F | 1 |
Imazu, Y; Kobayashi, K; Shohmori, T | 1 |
Shibutani, Y | 1 |
Maayan, ML; Sellitto, RV; Volpert, EM | 1 |
Flauto, C; Groppetti, A; Parati, E; Parenti, M; Rusconi, L; Vescovi, A | 1 |
Caporali, MG; Longo, VG; Ongini, E | 1 |
Bowman, RE; Levin, ED; Vuchetich, J; Wegert, S | 1 |
Fujita, M; Shimizu, T | 1 |
Sato, S | 1 |
Imazu, Y; Kobayashi, K; Shomori, T | 1 |
Hanew, K; Mizuno, Y; Sakuma, H; Takase, S; Teramura, K | 1 |
Goh, M; Hanew, K; Sasaki, A; Sato, S; Yoshinaga, K | 1 |
Goshima, Y; Kubo, T; Misu, Y | 2 |
Fujita, M; Kuroda, K; Motomura, N; Shimizu, T; Toyoda, K | 1 |
Aleksić, J; Geber, J; Gjuris, V; Ivanović, D; Marović, A; Reić, P; Sikirić, P; Suchanek, E | 1 |
Bános, C; Földes, J; Lakatos, P; Takó, J | 1 |
Bjørndal, N; Casey, D; Gerlach, J | 1 |
Groĭsman, SD; Karevina, TG; Khokholia, VP | 1 |
Hanew, K; Kasai, M; Murakami, O; Murata, K; Sasaki, A; Sato, S; Shimizu, Y; Yoshinaga, K | 1 |
Hanew, K; Kasai, M; Murakami, O; Sasaki, A; Sato, S; Shimizu, Y; Yoshinaga, K | 1 |
Aidara, D; Robyn, C; Tahiri-Zagret, C | 1 |
Barreca, T; Magnani, G; Rolandi, E; Sannia, A | 1 |
Benco, R; Caldara, R; Crosignani, PG; Ferrari, C; Rampini, P; Scarduelli, C | 1 |
Hanew, K; Sasaki, A; Sato, S; Yoshinaga, K | 1 |
Adam, WR; Campbell, DJ; Funder, JW; Mendelsohn, FA | 1 |
Crespi, R; Gattei, G; Zanoboni, A; Zanoboni-Muciaccia, W | 1 |
Fukuchi, H; Kihira, K; Kimura, Y; Kitaura, T; Miyake, K | 1 |
Gnanalingham, KK; Robertson, RG | 1 |
Crossman, AR; Graham, WC; Sambrook, MA | 1 |
Strange, PG | 1 |
Yanagisawa, N | 1 |
Akiguchi, I; Nakamura, S | 1 |
Guska, NI; Razlovan, TA; Sheptitskiĭ, VA | 1 |
Battistin, L; Dam, M; Fabbri, M; Pizzolato, G; Ricchieri, GL; Ruggero, S | 1 |
Hadjiconstantinou, M; Hubble, JP; Neff, NH; Sylvia, CP; Wemlinger, TA | 1 |
Ebinger, G; Michotte, Y; Sarre, S | 1 |
Derbiszewska, T; Nowak, JZ; Zawilska, JB | 1 |
Kołodziejczyk, K; Maj, J; Rogóz, Z; Skuza, G | 1 |
Baudewig, J; Bruns, D; Paulus, W; Tergau, F; Ziemann, U | 1 |
Agid, Y; Dziewczapolski, G; García, MC; Gershanik, O; Menalled, LB; Murer, MG; Raisman-Vozari, R | 1 |
Ebinger, G; Michotte, Y; Sarre, S; Smolders, I; Thorré, K | 1 |
Berndt, TJ; Knox, FG; LeClaire, MM | 1 |
Giladi, N; Melamed, E | 1 |
Delfino, M; Dziewczapolski, G; Ferrario, J; Gershanik, OS; Murer, MG; Raisman-Vozari, R | 1 |
Freed, WJ; Kishikawa, M; Takashima, H; Tsujihata, M | 1 |
Asmakova, LS; Bondarenko, NA; Gudasheva, TA; Kalinina, TS; Ostrovskaya, RU; Seredenin, SB; Voronina, TA; Zaitseva, NI | 1 |
Bernardi, G; Federici, M; Mercuri, NB | 1 |
Ferger, B; Schmidt, N; Schulz, JB; Teismann, P; Xia, XG | 1 |
Ohye, C; Shibazaki, T | 1 |
Innis, SM; Ng, KF | 1 |
Beckstead, MJ; Grandy, DK; Wickman, K; Williams, JT | 1 |
Gille, G; Radad, K; Rausch, WD; Reichmann, H | 1 |
Antal, A; Lampe, C; Lang, N; Liebetanz, D; Nitsche, MA; Paulus, W; Tergau, F | 1 |
Aceves, J; Cortes, H; Erlij, D; Escartín, E; Florán, B; Florán, L; Rangel, C; Silva, I | 1 |
Dimpfel, W | 1 |
Bergner, C; Grosch, J; Kuo, MF; Monte-Silva, K; Nitsche, MA; Paulus, W | 1 |
Marti, M; Morari, M; Viaro, R | 1 |
Cobacho, N; De la Calle, JL; González-Escalada, JR; Paíno, CL | 1 |
Fresnoza, S; Kuo, MF; Nitsche, MA; Paulus, W | 1 |
Bagetta, V; Branchi, I; Calabresi, P; Ghiglieri, V; Latagliata, EC; Morelli, E; Pascucci, T; Pendolino, V; Picconi, B; Poggini, S; Puglisi-Allegra, S; Sgobio, C | 1 |
Bestmann, S; Galea, JM; Rothwell, J; Ruge, D | 1 |
Kumei, S; Miyagishi, S; Nozu, T; Ohhira, M; Okumura, T; Takakusaki, K | 1 |
Kasuya, E; Sutoh, M; Yayou, KI | 1 |
Aslanoglou, D; Benner, V; Farino, ZJ; Freyberg, Z; Lopez-Valencia, M; McCarthy, MJ; Osborn, O; Wei, H; Zapata, RC | 1 |
5 review(s) available for sulpiride and levodopa
Article | Year |
---|---|
[Psychiatric manifestations induced by dopamine precursors or antagonists].
Topics: Anxiety; Bromocriptine; Confusion; Dopamine Antagonists; Dreams; Female; Hallucinations; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Sulpiride | 1979 |
[Determination of serum prolactin].
Topics: 5-Hydroxytryptophan; Amenorrhea; Brain Diseases; Chlorpromazine; Female; Galactorrhea; Humans; Hypothalamus; Levodopa; Male; Methods; Pituitary Diseases; Pregnancy; Prolactin; Sleep; Sulpiride; Thyrotropin-Releasing Hormone; Water | 1976 |
Is aldosterone secretion under dopaminergic control?
Topics: Aldosterone; Bromocriptine; Chlorpromazine; Dopamine; Dopamine Antagonists; Edema; Humans; Levodopa; Methyldopa; Metoclopramide; Parkinson Disease; Sulpiride | 1981 |
Dopamine receptors in the basal ganglia: relevance to Parkinson's disease.
Topics: Basal Ganglia; Basal Ganglia Diseases; Brain; Clozapine; Dopamine Agents; Dopamine D2 Receptor Antagonists; Female; Haloperidol; Humans; Levodopa; Male; Neostriatum; Neural Pathways; Parkinson Disease; Receptors, Dopamine D1; Receptors, Dopamine D2; Sulpiride | 1993 |
[Oral dyskinesis, facial dystonia].
Topics: Dyskinesia, Drug-Induced; Dystonia; Face; Female; Humans; Levodopa; Male; Meige Syndrome; Mouth; Movement Disorders; Receptors, Dopamine D1; Sulpiride; Tiapamil Hydrochloride; Trihexyphenidyl | 1993 |
5 trial(s) available for sulpiride and levodopa
Article | Year |
---|---|
Specific effects of the benzodiazepine midazolam on visual receptive fields in light and dark adapted human subjects.
Topics: Adaptation, Ocular; Adult; Atropine; Dark Adaptation; Dose-Response Relationship, Drug; Female; Humans; Levodopa; Male; Midazolam; Photic Stimulation; Sulpiride; Visual Fields | 1992 |
Changes in human motor cortex excitability induced by dopaminergic and anti-dopaminergic drugs.
Topics: Administration, Oral; Adult; Analysis of Variance; Bromocriptine; Dopamine Agonists; Dopamine Antagonists; Electromyography; Evoked Potentials, Motor; Female; Haloperidol; Humans; Levodopa; Magnetics; Male; Motor Cortex; Physical Stimulation; Reference Values; Selegiline; Sulpiride | 1997 |
Dopaminergic modulation of long-lasting direct current-induced cortical excitability changes in the human motor cortex.
Topics: Adult; Dopamine; Dopamine Agents; Dopamine Agonists; Dopamine Antagonists; Electrophysiology; Female; Humans; Levodopa; Magnetoencephalography; Male; Motor Cortex; Neuronal Plasticity; Pergolide; Receptors, Dopamine D1; Receptors, Dopamine D2; Sulpiride; Transcranial Magnetic Stimulation | 2006 |
D1-receptor impact on neuroplasticity in humans.
Topics: Adult; Analysis of Variance; Dopamine Agents; Electric Stimulation; Evoked Potentials, Motor; Female; Humans; Levodopa; Male; Motor Cortex; Neuronal Plasticity; Receptors, Dopamine D1; Sulpiride; Transcranial Magnetic Stimulation; Young Adult | 2009 |
Nonlinear dose-dependent impact of D1 receptor activation on motor cortex plasticity in humans.
Topics: Adult; Dopamine Agents; Dopamine Antagonists; Double-Blind Method; Evoked Potentials, Motor; Female; Humans; Levodopa; Male; Motor Cortex; Neuronal Plasticity; Nonlinear Dynamics; Receptors, Dopamine D1; Sulpiride; Transcranial Magnetic Stimulation | 2014 |
90 other study(ies) available for sulpiride and levodopa
Article | Year |
---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Predicting phenolic acid absorption in Caco-2 cells: a theoretical permeability model and mechanistic study.
Topics: Artificial Intelligence; Caco-2 Cells; Cell Membrane Permeability; Cinnamates; Enterocytes; Humans; Hydrophobic and Hydrophilic Interactions; Intestinal Absorption; Kinetics; Models, Biological; Molecular Conformation; Osmolar Concentration; Phenols | 2012 |
[The Cools and van Rossum theory and the pharmacology of Huntington's chorea].
Topics: Animals; Apomorphine; Brain; Cats; Dopamine; Dopamine beta-Hydroxylase; Drug Therapy, Combination; Ergonovine; Huntington Disease; Levodopa; Rats; Sulpiride; Tyrosine 3-Monooxygenase | 1977 |
Enhanced TSH stimulating effect of TRH by sulpiride in man.
Topics: Adult; Humans; Levodopa; Male; Receptors, Dopamine; Sulpiride; Thyrotropin; Thyrotropin-Releasing Hormone | 1979 |
Amines and the rat exocrine pancreas: (3) Effects of amines on pancreatic secretion.
Topics: 5-Hydroxytryptophan; Amines; Animals; Bicarbonates; Haloperidol; Levodopa; Male; Monoamine Oxidase Inhibitors; Pancreatic Juice; Phenoxybenzamine; Phenylephrine; Proteins; Rats; Secretin; Secretory Rate; Sulpiride | 1979 |
Effect of sulpiride on serum growth hormone and prolactin concentrations following L-DOPA administration in man.
Topics: Administration, Oral; Adult; Aged; Female; Growth Hormone; Humans; Levodopa; Male; Middle Aged; Prolactin; Sulpiride; Thyrotropin; Thyrotropin-Releasing Hormone; Time Factors | 1977 |
Effect of sulpiride and L-dopa on anterior pituitary hormones in plasma of normal men and women.
Topics: Female; Follicle Stimulating Hormone; Growth Hormone; Humans; Levodopa; Luteinizing Hormone; Male; Middle Aged; Pituitary Hormones, Anterior; Prolactin; Sulpiride; Thyrotropin | 1979 |
[Value of sulpiride and tiapride in geriatrics. Antagonism between Parkinson disease and chorea].
Topics: Aged; Benzamides; Chorea; Dyskinesia, Drug-Induced; Humans; Levodopa; Parkinson Disease; Sulpiride; Tiapamil Hydrochloride | 1979 |
Stimulating action of sulpiride and pimozide on prolactin release. Effect on bromocriptine, L-dopa and metergoline administration.
Topics: Adolescent; Adult; Bromocriptine; Ergolines; Female; Humans; Levodopa; Male; Metergoline; Pimozide; Prolactin; Sulpiride | 1977 |
Acute endocrine profile of sulpiride in the human.
Topics: Adolescent; Adult; Female; Follicle Stimulating Hormone; Growth Hormone; Humans; Levodopa; Luteal Phase; Luteinizing Hormone; Male; Middle Aged; Pituitary Hormones, Anterior; Prolactin; Secretory Rate; Sulpiride; Thyrotropin | 1978 |
[Secretion of prolactin: the value of dynamic studies].
Topics: Breast Feeding; Circadian Rhythm; Female; Humans; Hypothalamo-Hypophyseal System; Lactation Disorders; Levodopa; Pituitary Diseases; Pituitary Neoplasms; Pregnancy; Prolactin; Sulpiride; Thyrotropin-Releasing Hormone | 1975 |
Central effects of thyrotropin-releasing factor (TRF); interaction with some antipsychotic drugs.
Topics: Animals; Behavior, Animal; Chlorpromazine; Drug Interactions; Haloperidol; Injections, Intraventricular; Levodopa; Mice; Reserpine; Sulpiride; Thyrotropin-Releasing Hormone; Time Factors | 1976 |
In vivo binding of 3H-pimozide in mouse striatum: effects of dopamine agonists and antagonists.
Topics: Animals; Apomorphine; Cerebellum; Cerebral Cortex; Corpus Striatum; Dextroamphetamine; Haloperidol; Homovanillic Acid; Levodopa; Male; Mice; Pimozide; Receptors, Dopamine; Sulpiride | 1977 |
Effect of sulpiride on plasma prolactin in rats.
Topics: Animals; Hypothalamus; Injections, Intravenous; Injections, Intraventricular; Levodopa; Male; Prolactin; Rats; Sulpiride | 1976 |
Influence of dopaminergic agonists and antagonists on serum prolactin concentrations in the rat.
Topics: Animals; Apomorphine; Benserazide; Clonidine; Dextroamphetamine; Dopamine; Female; Haloperidol; Hypophysectomy; Levodopa; Male; Methyltyrosines; Piribedil; Pituitary Gland; Prolactin; Rats; Reserpine; Sulpiride; Transplantation, Homologous | 1976 |
[Prevention with sulpiride of the inhibitory effect of L-DOPA on prolactin secretion].
Topics: Adult; Drug Interactions; Humans; Levodopa; Male; Pituitary Gland; Pituitary Gland, Anterior; Prolactin; Sulpiride | 1975 |
[Ineffectiveness of L-DOPA on hyperprolactinemia induced with sulpiride].
Topics: Adult; Drug Interactions; Humans; Levodopa; Male; Pituitary Gland; Pituitary Gland, Anterior; Prolactin; Sulpiride | 1975 |
Levodopa-induced dyskinesias in Parkinson's disease: clinical and pharmacological classification.
Topics: Aged; Apomorphine; Chlorpromazine; Dopamine Agents; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Electromyography; Female; Humans; Levodopa; Lisuride; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Parkinson Disease, Secondary; Receptors, Dopamine; Sulpiride | 1992 |
Actions of levodopa on rat substantia nigra zona compacta neurons.
Topics: Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Carbidopa; Cocaine; Female; Levodopa; Male; Neurons; Nomifensine; Rats; Rats, Wistar; Substantia Nigra; Sulpiride | 1992 |
L-dopa induces opposing effects on pain in intact rats: (-)-sulpiride, SCH 23390 or alpha-methyl-DL-p-tyrosine methylester hydrochloride reveals profound hyperalgesia in large antinociceptive doses.
Topics: Analgesics; Animals; Benzazepines; Catecholamines; Drug Interactions; Electric Stimulation; Hyperalgesia; Levodopa; Male; Methyltyrosines; Pain; Pain Threshold; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Sulpiride; Time Factors; Vocalization, Animal | 1992 |
Neurochemical profile of EMD 45609 (carmoxirole), a dopamine DA2-receptor agonist.
Topics: Animals; Biogenic Amines; Brain; Clonidine; Corpus Striatum; Dopamine; Dopamine Agents; Drug Interactions; Ergolines; Heart; Hypothalamus; Indoles; Levodopa; Male; Motor Activity; Norepinephrine; Oxidopamine; Pyridines; Quinpirole; Rats; Rats, Inbred Strains; Receptors, Dopamine; Reserpine; Sulpiride | 1991 |
Dopamine uptake inhibition potentiates the effects of L-DOPA on rat substantia nigra zona compacta neurons.
Topics: Action Potentials; Amphetamine; Animals; Biological Transport; Cocaine; Dopamine; Dopamine Antagonists; Drug Synergism; Female; In Vitro Techniques; Levodopa; Male; Neurons; Neurotransmitter Uptake Inhibitors; Nomifensine; Rats; Rats, Inbred Strains; Substantia Nigra; Sulpiride | 1991 |
L-dihydroxyphenylalanine methyl ester is a potent competitive antagonist of the L-dihydroxyphenylalanine-induced facilitation of the evoked release of endogenous norepinephrine from rat hypothalamic slices.
Topics: Animals; Binding, Competitive; Carbidopa; Cocaine; Hydrazines; Hypothalamus; In Vitro Techniques; Levodopa; Norepinephrine; Propranolol; Rats; Structure-Activity Relationship; Sulpiride | 1991 |
L-dopa stimulates the release of [3H]gamma-aminobutyric acid in the basal ganglia of 6-hydroxydopamine lesioned rats.
Topics: Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Basal Ganglia; Benzazepines; Brain Chemistry; Dopamine Antagonists; gamma-Aminobutyric Acid; Hydrazines; Hydroxydopamines; In Vitro Techniques; Levodopa; Male; Nerve Degeneration; Oxidopamine; Potassium; Rats; Rats, Inbred Strains; Sulpiride; Sympathectomy, Chemical | 1991 |
Hyperprolactinemia in multiple sclerosis.
Topics: Adult; Bromocriptine; Dopamine; Female; Galactorrhea; Humans; Hyperprolactinemia; Hypothalamus; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Prolactin; Sulpiride; Thyrotropin-Releasing Hormone | 1991 |
Differential ability of selective and non-selective dopamine agonists to induce climbing in the rat indicates the involvement of both D-1 and D-2 receptors in this behaviour.
Topics: Amphetamine; Animals; Apomorphine; Benzazepines; Bromocriptine; Clonidine; Dopamine Agents; Ergolines; Female; Levodopa; Motor Activity; Pergolide; Quinpirole; Rats; Rats, Inbred Strains; Receptors, Dopamine; Stereotyped Behavior; Sulpiride | 1990 |
Neuroleptic-induced catalepsy as a model of Parkinson's disease. I. Effect of dopaminergic agents.
Topics: Animals; Antipsychotic Agents; Catalepsy; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Fluphenazine; Levodopa; Male; Methamphetamine; Microinjections; Parkinson Disease; Rats; Sulpiride | 1990 |
Responses of rat substantia nigra compacta neurones to L-DOPA.
Topics: Animals; Calcium Channel Blockers; Carbidopa; Cobalt; Dopamine; Female; In Vitro Techniques; Levodopa; Male; Membrane Potentials; Neurons; Rats; Rats, Inbred Strains; Sodium Channels; Substantia Nigra; Sulpiride; Tetrodotoxin | 1990 |
Inhibitory action of L-dopa.
Topics: Animals; Humans; Levodopa; Mice; Parkinson Disease; Receptors, Dopamine; Receptors, Dopamine D2; Sulpiride | 1989 |
Comparative study of sulpiride and haloperidol on dopamine turnover in the rat brain.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Apomorphine; Brain; Dopamine; Haloperidol; Levodopa; Male; Rats; Rats, Inbred Strains; Sulpiride | 1989 |
Prolactin dynamics in a patient with isolated ACTH deficiency accompanied by hyperprolactinemia.
Topics: Adrenocorticotropic Hormone; Aged; Humans; Hyperprolactinemia; Levodopa; Male; Prolactin; Sulpiride; Thyrotropin-Releasing Hormone | 1988 |
Dopamine and L-dopa: inhibition of thyrotropin-stimulated thyroidal thyroxine release.
Topics: Adrenergic alpha-Antagonists; Animals; Apomorphine; Aromatic Amino Acid Decarboxylase Inhibitors; Atropine; Bucladesine; Carbidopa; Cyclic AMP; Dopamine; Dopamine beta-Hydroxylase; Female; Levodopa; Mice; Receptors, Adrenergic, alpha; Receptors, Dopamine; Sulpiride; Thyroid Gland; Thyrotropin; Thyroxine | 1986 |
Dopamine receptor changes in response to prolonged treatment with L-dopa.
Topics: Adenylyl Cyclases; Animals; Apomorphine; Benzazepines; Carbidopa; Corpus Striatum; Dopamine; Hydroxydopamines; Levodopa; Male; Oxidopamine; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1; Spiperone; Stereotyped Behavior; Substantia Nigra; Sulpiride | 1986 |
Blockade of D-1 dopamine receptors by SCH 23390 prevents EEG and behavioral activation induced by L-dopa.
Topics: Animals; Behavior, Animal; Benzazepines; Electroencephalography; Haloperidol; Levodopa; Male; Rabbits; Receptors, Dopamine; Receptors, Dopamine D1; Sulpiride | 1987 |
Psychopharmacological investigations of a lead-induced long-term cognitive deficit in monkeys.
Topics: Acetylcholine; Amphetamine; Animals; Behavior, Animal; Cognition Disorders; Dopamine; Haloperidol; Lead Poisoning; Levodopa; Macaca mulatta; Physostigmine; Scopolamine; Sulpiride | 1987 |
A neuroendocrinological investigation of patients with senile demantia of Alzheimer type. Plasma prolactin and GH responses following TRH, sulpiride, L-dopa, and bromocriptine administration.
Topics: Aged; Alzheimer Disease; Bromocriptine; Dopamine; Female; Growth Hormone; Humans; Hypothalamus; Kinetics; Levodopa; Male; Middle Aged; Prolactin; Sulpiride; Thyrotropin-Releasing Hormone | 1986 |
[The properties of prolactin secretion in patients with prolactin secreting pituitary adenomas].
Topics: Adenoma; Adolescent; Adult; Arginine; Dopamine; Female; Humans; Levodopa; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Sulpiride; Thyrotropin; Thyrotropin-Releasing Hormone | 1987 |
[Difference in mechanism of action of sulpiride and haloperidol on dopamine brain turnover].
Topics: Animals; Brain; Dopamine; Haloperidol; Levodopa; Male; Rats; Rats, Inbred Strains; Receptors, Dopamine; Sulpiride | 1988 |
Hypothalamo-pituitary dopaminergic system in patients with myotonic dystrophy.
Topics: Adolescent; Adult; Bromocriptine; Dopamine; Female; Growth Hormone; Humans; Hypothalamo-Hypophyseal System; Levodopa; Male; Middle Aged; Muscular Dystrophies; Prolactin; Sulpiride | 1988 |
Growth hormone inhibitory and stimulatory actions of L-dopa in patients with acromegaly.
Topics: Acromegaly; Adult; Blood-Brain Barrier; Bromocriptine; Domperidone; Dopamine; Female; Growth Hormone; Humans; Levodopa; Male; Middle Aged; Prolactin; Sulpiride | 1987 |
Biphasic actions of L-DOPA on the release of endogenous noradrenaline and dopamine from rat hypothalamic slices.
Topics: Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Brocresine; Cresols; Dopamine; Electric Stimulation; Female; Hypothalamus; In Vitro Techniques; Levodopa; Norepinephrine; Rats; Rats, Inbred Strains; Sulpiride | 1986 |
Biphasic actions of L-DOPA on the release of endogenous dopamine via presynaptic receptors in rat striatal slices.
Topics: Animals; Brocresine; Cocaine; Corpus Striatum; Dopamine; Drug Interactions; In Vitro Techniques; Levodopa; Male; Propranolol; Rats; Rats, Inbred Strains; Sulpiride | 1986 |
[Plasma prolactin and GH response after thyrotropin-releasing hormone (TRH), L-DOPA and sulpiride in patients with senile dementia of Alzheimer type].
Topics: Aged; Alzheimer Disease; Growth Hormone; Humans; Levodopa; Male; Middle Aged; Prolactin; Sulpiride; Thyrotropin-Releasing Hormone | 1985 |
The role of dopamine in the formation of gastric ulcers in rats.
Topics: Animals; Apomorphine; Bromocriptine; Domperidone; Dopamine; Female; Haloperidol; Levodopa; Male; Rats; Rats, Inbred Strains; Stomach Ulcer; Sulpiride | 1985 |
Effect of domperidone on serum TSH and growth hormone in thyroid patients.
Topics: Adult; Domperidone; Female; Growth Hormone; Humans; Levodopa; Middle Aged; Stimulation, Chemical; Sulpiride; Thyroid Diseases; Thyrotropin | 1985 |
Dopamine antagonist and agonist treatment of tardive dyskinesia.
Topics: Antipsychotic Agents; Benserazide; Benzimidazoles; Dopamine; Dopamine Antagonists; Dyskinesia, Drug-Induced; Humans; Levodopa; Sulpiride | 1980 |
[Role of dopamine receptors in the mechanism of formation of stress-induced stomach lesions].
Topics: Animals; Apomorphine; Female; Gastrointestinal Hemorrhage; Humans; Levodopa; Male; Metoclopramide; Rats; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Stomach Ulcer; Stress, Psychological; Sulpiride; Vagotomy | 1984 |
Persistence of impaired PRL responses to sulpiride in patients with PRL secreting pituitary adenomas after successful hypophysectomy.
Topics: Adenoma; Adolescent; Adult; Arginine; Female; Humans; Hypophysectomy; Levodopa; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Sulpiride; Thyrotropin-Releasing Hormone | 1983 |
Plasma growth hormone responses to sulpiride in patients with acromegaly.
Topics: Acromegaly; Adult; Domperidone; Dopamine; Female; Growth Hormone; Humans; Hypophysectomy; Levodopa; Male; Middle Aged; Prolactin; Sulpiride; Thyrotropin-Releasing Hormone | 1984 |
Serum prolactin concentrations in mangabey (Cercocebus atys lunulatus) and patas (Erythrocebus patas) monkeys in response to stress, ketamine, TRH, sulpiride and levodopa.
Topics: Animals; Cercopithecidae; Erythrocebus patas; Female; Humans; Ketamine; Levodopa; Male; Prolactin; Radioimmunoassay; Stress, Psychological; Sulpiride; Thyrotropin-Releasing Hormone | 1981 |
Evaluation of Prl secretion in elderly subjects.
Topics: Age Factors; Aged; Female; Humans; Levodopa; Male; Prolactin; Sex Factors; Sulpiride; Thyrotropin-Releasing Hormone; Time Factors | 1982 |
Functional characterization of hypothalamic hyperprolactinemia.
Topics: Adult; Aged; Carbidopa; Child; Dopamine; Female; Humans; Hypothalamic Diseases; Levodopa; Male; Meningeal Neoplasms; Middle Aged; Nomifensine; Pituitary Neoplasms; Prolactin; Sulpiride; Thyrotropin-Releasing Hormone | 1982 |
Evidence for endogenous dopaminergic regulation of thyrotropin (TSH) secretion in man.
Topics: Adult; Dopamine; Female; Humans; Kinetics; Levodopa; Male; Radioimmunoassay; Sex Factors; Sulpiride; Thyrotropin | 1983 |
Failure of carbidopa and L-dopa to suppress the prolactin stimulating effect of sulpiride in normal man.
Topics: Adult; Carbidopa; Humans; Levodopa; Male; Prolactin; Sulpiride | 1980 |
Effects of L-dopa on cholecystokinin octapeptide tissue levels in normal and 6-hydroxydopamine-treated rat brain.
Topics: Animals; Brain Chemistry; Dopamine; Levodopa; Male; Oxidopamine; Radioimmunoassay; Rats; Rats, Wistar; Sincalide; Sulpiride | 1995 |
The effects of chronic continuous versus intermittent levodopa treatments on striatal and extrastriatal D1 and D2 dopamine receptors and dopamine uptake sites in the 6-hydroxydopamine lesioned rat--an autoradiographic study.
Topics: Animals; Apomorphine; Autoradiography; Behavior, Animal; Benzazepines; Dopamine; Levodopa; Male; Mazindol; Medial Forebrain Bundle; Neostriatum; Oxidopamine; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Stereotyped Behavior; Sulpiride | 1994 |
Differential effect of chronic dopaminergic treatment on dopamine D1 and D2 receptors in the monkey brain in MPTP-induced parkinsonism.
Topics: Animals; Apomorphine; Autoradiography; Benzazepines; Brain Chemistry; Caudate Nucleus; Dopamine Agents; Female; Infusions, Intravenous; Levodopa; Macaca fascicularis; Male; MPTP Poisoning; Parkinson Disease, Secondary; Putamen; Receptors, Dopamine D1; Receptors, Dopamine D2; Sulpiride | 1993 |
[Diagnosis and treatment of Parkinson's disease in the elderly].
Topics: Aged; Brain; Bromocriptine; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Sulpiride; Tiapamil Hydrochloride | 1993 |
[The role of dopamine in the mechanism of the regulation of the digestive-transport functions of the enterocyte membrane during stress].
Topics: Animals; Biological Transport; Cell Membrane; Digestion; Dopamine; Dose-Response Relationship, Drug; Intestinal Absorption; Intestine, Small; Levodopa; Rats; Rats, Wistar; Restraint, Physical; Stress, Psychological; Sulpiride | 1993 |
Selective D1 or D2 receptor blockade. Effects on brain functional responses to L-dopa.
Topics: Animals; Benzazepines; Blood Glucose; Brain; Brain Mapping; Deoxyglucose; Dopamine; Dopamine D2 Receptor Antagonists; Energy Metabolism; Levodopa; Male; Rats; Rats, Inbred F344; Receptors, Dopamine D1; Receptors, Dopamine D2; Stereotyped Behavior; Sulpiride | 1993 |
Aromatic L-amino acid decarboxylase activity of mouse striatum is modulated via dopamine receptors.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Aromatic-L-Amino-Acid Decarboxylases; Benzazepines; Bromocriptine; Corpus Striatum; Cycloheximide; Dopamine Antagonists; Haloperidol; Kinetics; Levodopa; Male; Mice; Pyridoxal Phosphate; Receptors, Dopamine; Reserpine; Sulpiride; Time Factors | 1993 |
Levodopa biotransformation in hemi-Parkinson rats: effect of dopamine receptor agonists and antagonists.
Topics: Animals; Antiparkinson Agents; Benzazepines; Biotransformation; Corpus Striatum; Denervation; Dopamine Agonists; Dopamine Antagonists; Levodopa; Male; Parkinson Disease; Quinpirole; Rats; Rats, Wistar; Sulpiride | 1996 |
Pharmacological modifications in dopaminergic neurotransmission affect the quinpirole-evoked suppression of serotonin N-acetyltransferase activity in chick retina: an impact on dopamine D4-like receptors.
Topics: Animals; Antipsychotic Agents; Arylamine N-Acetyltransferase; Chickens; Circadian Rhythm; Clozapine; Dopamine Agents; Enzyme Inhibitors; Levodopa; Male; Quinpirole; Raclopride; Receptors, Dopamine D2; Receptors, Dopamine D4; Retina; Salicylamides; Sulpiride; Synaptic Transmission | 1996 |
The behavioural effects of pramipexole, a novel dopamine receptor agonist.
Topics: Animals; Antiparkinson Agents; Benzazepines; Benzothiazoles; Body Temperature; Catalepsy; Clozapine; Dopamine Agents; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Dyskinesia, Drug-Induced; Haloperidol; Injections, Subcutaneous; Levodopa; Male; Mice; Motor Activity; Pramipexole; Rats; Rats, Wistar; Receptors, Dopamine D2; Receptors, Dopamine D3; Spiperone; Stereotyped Behavior; Sulpiride; Thiazoles | 1997 |
Chronic levodopa is not toxic for remaining dopamine neurons, but instead promotes their recovery, in rats with moderate nigrostriatal lesions.
Topics: Amphetamine; Animals; Antiparkinson Agents; Apomorphine; Behavior, Animal; Carrier Proteins; Disease Models, Animal; Dopamine; Dopamine Agonists; Dopamine Antagonists; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Female; Iodine Radioisotopes; Levodopa; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Fibers; Nerve Tissue Proteins; Neuropeptides; Neurotransmitter Agents; Oxidopamine; Parkinson Disease, Secondary; Prosencephalon; Radioimmunoassay; Rats; Rats, Wistar; Substantia Nigra; Sulpiride; Sympatholytics; Tyrosine 3-Monooxygenase; Ventral Tegmental Area; Vesicular Biogenic Amine Transport Proteins; Vesicular Monoamine Transport Proteins | 1998 |
Dopaminergic regulation of serotonin release in the substantia nigra of the freely moving rat using microdialysis.
Topics: Animals; Benzazepines; Dopamine Agents; Dopamine Agonists; Dopamine Antagonists; Levodopa; Male; Microdialysis; Rats; Rats, Wistar; Receptors, Dopamine D1; Receptors, Dopamine D2; Serotonin; Substantia Nigra; Sulpiride | 1998 |
Effect of renal interstitial infusion of L-dopa on sodium and phosphate excretions.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Dopamine; Dopamine Agents; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Infusions, Parenteral; Kidney Tubules, Proximal; Levodopa; Male; Natriuresis; Phosphates; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Sodium; Sulpiride | 1998 |
Levodopa therapy can ameliorate tetrabenazine-induced parkinsonism.
Topics: Aged; Antiparkinson Agents; Blepharospasm; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Middle Aged; Neurologic Examination; Parkinson Disease, Secondary; Recurrence; Sulpiride; Tetrabenazine | 1999 |
Increased [125I]sulpiride binding in the subthalamic nucleus of rats with nigrostriatal lesions.
Topics: Administration, Oral; Animals; Antiparkinson Agents; Brain Mapping; Corpus Striatum; Dopamine; Dopamine Antagonists; Female; Iodine Radioisotopes; Levodopa; Neurons; Oxidopamine; Radioligand Assay; Rats; Rats, Wistar; Substantia Nigra; Sulpiride; Thalamic Nuclei | 1999 |
Bromocriptine protects dopaminergic neurons from levodopa-induced toxicity by stimulating D(2)receptors.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Antiparkinson Agents; Antisense Elements (Genetics); Autoreceptors; Bromocriptine; Cell Survival; Cells, Cultured; Dopamine; Dopamine Agents; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Female; Fetus; Fluoresceins; Free Radicals; Gene Expression; Levodopa; Mesencephalon; Nerve Degeneration; Neurons; Neuroprotective Agents; Neurotoxins; Pregnancy; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Sulpiride; Tyrosine 3-Monooxygenase | 1999 |
Comparison of antipsychotic activity and discriminative stimulus effects of the novel acylprolyltyrosine containing compound, GZR-123, and sulpiride.
Topics: Animals; Antipsychotic Agents; Apomorphine; Catalepsy; Discrimination, Psychological; Dopamine Agents; Dopamine Agonists; Exploratory Behavior; Levodopa; Male; Mice; Mice, Inbred C57BL; Motor Activity; Proline; Rats; Rats, Wistar; Stereotyped Behavior; Sulpiride; Tyrosine | 1999 |
Inhibition of catechol-O-methyltransferase (COMT) in the brain does not affect the action of dopamine and levodopa: an in vitro electrophysiological evidence from rat mesencephalic dopamine neurons.
Topics: Animals; Benzophenones; Catechol O-Methyltransferase Inhibitors; Cells, Cultured; Dopamine; Dopamine Antagonists; Electrophysiology; Enzyme Inhibitors; GABA Antagonists; Glycine Agents; Levodopa; Male; Neurons; Nitrophenols; Organophosphorus Compounds; Parkinson Disease; Picrotoxin; Rats; Rats, Wistar; Strychnine; Substantia Nigra; Sulpiride; Synaptic Transmission; Tolcapone; Ventral Tegmental Area | 1999 |
Dopamine mediates striatal malonate toxicity via dopamine transporter-dependent generation of reactive oxygen species and D2 but not D1 receptor activation.
Topics: 3,4-Dihydroxyphenylacetic Acid; alpha-Methyltyrosine; Animals; Benzazepines; Brain Diseases; Carbidopa; Carrier Proteins; Corpus Striatum; Dizocilpine Maleate; Dopamine; Dopamine D2 Receptor Antagonists; Dopamine Plasma Membrane Transport Proteins; Enzyme Inhibitors; Homovanillic Acid; Levodopa; Male; Malonates; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Neuropeptides; Oxidopamine; Rats; Rats, Wistar; Reactive Oxygen Species; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, N-Methyl-D-Aspartate; Reserpine; Succinate Dehydrogenase; Sulpiride; Vesicular Biogenic Amine Transport Proteins; Vesicular Monoamine Transport Proteins | 2001 |
Lesioning the thalamus for dyskinesia.
Topics: Antiparkinson Agents; Antipsychotic Agents; Dyskinesia, Drug-Induced; Dyskinesias; Electrocoagulation; Haloperidol; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Parkinsonian Disorders; Reoperation; Retrospective Studies; Schizophrenia; Stereotaxic Techniques; Sulpiride; Torticollis; Treatment Outcome; Tremor; Ventral Thalamic Nuclei | 2001 |
Behavioral responses are altered in piglets with decreased frontal cortex docosahexaenoic acid.
Topics: Aging; Animals; Animals, Newborn; Behavior, Animal; Brain; Diet; Dietary Fats, Unsaturated; Docosahexaenoic Acids; Dopamine; Dopamine D2 Receptor Antagonists; Energy Intake; Fatty Acids; Fatty Acids, Unsaturated; Frontal Lobe; Levodopa; Male; Organ Size; Phosphatidylcholines; Phosphatidylethanolamines; Phosphatidylinositols; Phosphatidylserines; Sulpiride; Swine; Weight Gain | 2003 |
Vesicular dopamine release elicits an inhibitory postsynaptic current in midbrain dopamine neurons.
Topics: Action Potentials; Adrenergic Uptake Inhibitors; Analysis of Variance; Animals; Calcium; Calcium Channel Blockers; Cocaine; Dopamine; Dopamine Agents; Dopamine Antagonists; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Electric Stimulation; Female; G Protein-Coupled Inwardly-Rectifying Potassium Channels; GABA Antagonists; In Vitro Techniques; Iontophoresis; Levodopa; Male; Mesencephalon; Mice; Mice, Inbred C57BL; Mice, Knockout; Neural Inhibition; Neurons; Organophosphorus Compounds; Potassium Channels; Potassium Channels, Inwardly Rectifying; Receptors, Dopamine D2; Receptors, Dopamine D3; Reserpine; Sodium Channel Blockers; Sulpiride; Tetrodotoxin | 2004 |
Synergistic effect of alpha-dihydroergocryptine and L-dopa or dopamine on dopaminergic neurons in primary culture.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Carbidopa; Cell Count; Cells, Cultured; Dihydroergocryptine; Dopamine; Dopamine Agents; Dopamine Antagonists; Drug Synergism; Female; Lactic Acid; Levodopa; Mice; Neuroglia; Neurons; Pregnancy; Sulpiride; Tyrosine 3-Monooxygenase | 2006 |
L-DOPA inhibits depolarization-induced [3H]GABA release in the dopamine-denervated globus pallidus of the rat: the effect is dopamine independent and mediated by D2-like receptors.
Topics: Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Data Interpretation, Statistical; Decarboxylation; Denervation; Dopamine; Dopamine Agents; Dopamine Antagonists; Enzyme Inhibitors; gamma-Aminobutyric Acid; Globus Pallidus; Hydrazines; Levodopa; Male; Medial Forebrain Bundle; Oxidopamine; Potassium; Rats; Rats, Wistar; Receptors, Dopamine D2; Stereotyped Behavior; Sulpiride; Sympathectomy, Chemical; Sympatholytics | 2006 |
Pharmacological modulation of dopaminergic brain activity and its reflection in spectral frequencies of the rat electropharmacogram.
Topics: Animals; Azepines; Brain; Dopamine Agents; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Electroencephalography; Levodopa; Microelectrodes; Quinpirole; Rats; Rats, Inbred F344; Receptors, Dopamine D2; Sulpiride | 2008 |
Dual motor response to l-dopa and nociceptin/orphanin FQ receptor antagonists in 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) treated mice: Paradoxical inhibition is relieved by D(2)/D(3) receptor blockade.
Topics: Amisulpride; Animals; Antiparkinson Agents; Benzimidazoles; Benzothiazoles; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Drug Interactions; Drug Synergism; Levodopa; Male; Mice; Mice, Inbred C57BL; Motor Activity; Neural Inhibition; Nociceptin; Opioid Peptides; Parkinsonian Disorders; Piperidines; Pramipexole; Pyridines; Reaction Time; Receptors, Dopamine D3; Sulpiride | 2010 |
Levodopa analgesia in experimental neuropathic pain.
Topics: Analgesics; Animals; Disease Models, Animal; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Functional Laterality; Hyperalgesia; Levodopa; Male; Motor Activity; Neuralgia; Pain Measurement; Pain Threshold; Psychomotor Performance; Rats; Rats, Sprague-Dawley; Rotarod Performance Test; Sulpiride; Time Factors | 2010 |
l-DOPA reverses the impairment of Dentate Gyrus LTD in experimental parkinsonism via β-adrenergic receptors.
Topics: Animals; Antiparkinson Agents; Benzazepines; Dentate Gyrus; Disease Models, Animal; Dopamine; Dopamine Antagonists; Electric Stimulation; Functional Laterality; Levodopa; Long-Term Synaptic Depression; Male; Microdialysis; Norepinephrine; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Wistar; Sulpiride | 2014 |
The role of dopamine in motor flexibility.
Topics: Adult; Anticipation, Psychological; Dopamine; Dopamine Agents; Double-Blind Method; Female; Haloperidol; Humans; Levodopa; Male; Probability; Psychomotor Performance; Reaction Time; Receptors, Dopamine D1; Receptors, Dopamine D2; Sulpiride | 2015 |
Levodopa acts centrally to induce an antinociceptive action against colonic distension through activation of D2 dopamine receptors and the orexinergic system in the brain in conscious rats.
Topics: Analgesics; Animals; Benzoxazoles; Brain; Consciousness; Injections, Intraventricular; Injections, Subcutaneous; Levodopa; Male; Naphthyridines; Orexin Receptor Antagonists; Orexin Receptors; Pain Threshold; Rats, Sprague-Dawley; Receptors, Dopamine D2; Sulpiride; Urea; Visceral Pain | 2016 |
The effects of l-DOPA and sulpiride on growth hormone secretion at different injection times in Holstein steers.
Topics: Animals; Cattle; Circadian Rhythm; Dopamine Agents; Dopamine D2 Receptor Antagonists; Dopaminergic Neurons; Growth Hormone; Injections, Intravenous; Levodopa; Male; Prolactin; Sulpiride | 2017 |
Dopamine D
Topics: Animals; Blood Glucose; Bromocriptine; Circadian Rhythm; Diabetes Mellitus, Type 2; Dopamine; Dopamine Agonists; Female; Glucose; Insulin; Insulin-Secreting Cells; Levodopa; Mice; Mice, Inbred C57BL; Obesity; Receptors, Dopamine D2; Sulpiride; Weight Gain | 2020 |